Related Experiment Video
Updated: Mar 16, 2026

12:08
Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
Published on: May 22, 2013
47.5K
Quantitative assays for measuring human telomerase activity and DNA binding properties
Christopher G Tomlinson1, Natsuki Sasaki1, Julie Jurczyluk1
1Children's Medical Research Institute, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia; University of Sydney, Sydney, NSW 2006, Australia.
Methods (San Diego, Calif.)
|August 11, 2016
Summary
Telomerase, an enzyme crucial in cancer, can be targeted for therapies. This study details methods to quantify telomerase activity, aiding in the development of new cancer drugs.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Telomerase is a ribonucleoprotein enzyme responsible for maintaining telomere length by adding DNA repeats to chromosome ends.
- Dysregulated telomerase expression is observed in approximately 90% of human cancers, making it a significant therapeutic target.
- Accurate measurement of telomerase activity is essential for evaluating potential anti-cancer drugs.
Purpose of the Study:
- To present standardized procedures for quantifying telomerase enzymology.
- To provide methods for assessing telomerase activity relevant to drug discovery and fundamental research.
- To detail assays for direct activity, DNA binding, DNA dissociation, and cell-based enzyme expression.
Main Methods:
- Direct telomerase activity assays.
- DNA binding and dissociation kinetic measurements.
- Cell-based overexpression of the active telomerase complex.
Main Results:
- Established quantitative assays for multiple facets of telomerase enzymology.
- Provided a framework for evaluating telomerase inhibitors.
- Enabled comprehensive analysis of enzyme kinetics and cellular expression.
Conclusions:
- The presented methods facilitate quantitative assessment of telomerase.
- These procedures are valuable for both basic research and the identification of novel cancer therapeutics.
- Quantitative enzymology is key to exploiting telomerase as a drug target.

